カテゴリー： QYResearch, 世界

慢性片頭痛治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Chronic Migraine Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18277）・商品コード：DATA909X18277
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：92
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、慢性片頭痛治療の世界市場について調査・分析し、慢性片頭痛治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、代替治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の慢性片頭痛治療市場動向
・主要企業別マーケットシェア
・慢性片頭痛治療の種類別市場規模2014-2019
（薬物治療、代替治療）
・慢性片頭痛治療の用途別市場規模2014-2019
（病院、診療所、その他）
・慢性片頭痛治療の北米市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療の中国市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療の日本国内市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療の東南アジア市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療のインド市場：主要企業・種類別/用途別市場規模
・慢性片頭痛治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Novartis、Pfizer、AstraZeneca、Allergan、GlaxoSmithKline、Eli Lilly、Merck、Johnson&Johnson、Zosano、Alder BioPharmaceuticals）
・慢性片頭痛治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics to migraine attacks.In 2018, the global Chronic Migraine Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Migraine Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study
Novartis
Pfizer
AstraZeneca
Allergan
GlaxoSmithKline
Eli Lilly
Merck
Johnson&Johnson
Zosano
Alder BioPharmaceuticals

Market segment by Type, the product can be split into
Drug Treatment
Substitution Treatment

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key players.
To present the Chronic Migraine Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Migraine Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Migraine Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Treatment
1.4.3 Substitution Treatment
1.5 Market by Application
1.5.1 Global Chronic Migraine Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chronic Migraine Treatment Market Size
2.2 Chronic Migraine Treatment Growth Trends by Regions
2.2.1 Chronic Migraine Treatment Market Size by Regions (2019-2025)
2.2.2 Chronic Migraine Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Chronic Migraine Treatment Market Size by by Players
3.1.1 Global Chronic Migraine Treatment Revenue by by Players (2014-2019)
3.1.2 Global Chronic Migraine Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Chronic Migraine Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Migraine Treatment Key Players Head office and Area Served
3.3 Key Players Chronic Migraine Treatment Product/Solution/Service
3.4 Date of Enter into Chronic Migraine Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chronic Migraine Treatment Market Size by Type (2014-2019)
4.2 Global Chronic Migraine Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Chronic Migraine Treatment Market Size (2014-2019)
5.2 Chronic Migraine Treatment Key Players in North America
5.3 North America Chronic Migraine Treatment Market Size by Type
5.4 North America Chronic Migraine Treatment Market Size by Application

6 Europe
6.1 Europe Chronic Migraine Treatment Market Size (2014-2019)
6.2 Chronic Migraine Treatment Key Players in Europe
6.3 Europe Chronic Migraine Treatment Market Size by Type
6.4 Europe Chronic Migraine Treatment Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Chronic Migraine Treatment Market Size (2014-2019)
7.2 Chronic Migraine Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Chronic Migraine Treatment Market Size by Type
7.4 Asia-Pacific Chronic Migraine Treatment Market Size by Application

8 International Players Profiles
8.1 Novartis
8.1.1 Novartis Company Details
8.1.2 Company Description and Business Overview
8.1.3 Chronic Migraine Treatment Introduction
8.1.4 Novartis Revenue in Chronic Migraine Treatment Business (2014-2019))
8.1.5 Novartis Recent Development
8.2 Pfizer
8.2.1 Pfizer Company Details
8.2.2 Company Description and Business Overview
8.2.3 Chronic Migraine Treatment Introduction
8.2.4 Pfizer Revenue in Chronic Migraine Treatment Business (2014-2019)
8.2.5 Pfizer Recent Development
8.3 AstraZeneca
8.3.1 AstraZeneca Company Details
8.3.2 Company Description and Business Overview
8.3.3 Chronic Migraine Treatment Introduction
8.3.4 AstraZeneca Revenue in Chronic Migraine Treatment Business (2014-2019)
8.3.5 AstraZeneca Recent Development
8.4 Allergan
8.4.1 Allergan Company Details
8.4.2 Company Description and Business Overview
8.4.3 Chronic Migraine Treatment Introduction
8.4.4 Allergan Revenue in Chronic Migraine Treatment Business (2014-2019)
8.4.5 Allergan Recent Development
8.5 GlaxoSmithKline
8.5.1 GlaxoSmithKline Company Details
8.5.2 Company Description and Business Overview
8.5.3 Chronic Migraine Treatment Introduction
8.5.4 GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2014-2019)
8.5.5 GlaxoSmithKline Recent Development
8.6 Eli Lilly
8.6.1 Eli Lilly Company Details
8.6.2 Company Description and Business Overview
8.6.3 Chronic Migraine Treatment Introduction
8.6.4 Eli Lilly Revenue in Chronic Migraine Treatment Business (2014-2019)
8.6.5 Eli Lilly Recent Development
8.7 Merck
8.7.1 Merck Company Details
8.7.2 Company Description and Business Overview
8.7.3 Chronic Migraine Treatment Introduction
8.7.4 Merck Revenue in Chronic Migraine Treatment Business (2014-2019)
8.7.5 Merck Recent Development
8.8 Johnson&Johnson
8.8.1 Johnson&Johnson Company Details
8.8.2 Company Description and Business Overview
8.8.3 Chronic Migraine Treatment Introduction
8.8.4 Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2014-2019)
8.8.5 Johnson&Johnson Recent Development
8.9 Zosano
8.9.1 Zosano Company Details
8.9.2 Company Description and Business Overview
8.9.3 Chronic Migraine Treatment Introduction
8.9.4 Zosano Revenue in Chronic Migraine Treatment Business (2014-2019)
8.9.5 Zosano Recent Development
8.10 Alder BioPharmaceuticals
8.10.1 Alder BioPharmaceuticals Company Details
8.10.2 Company Description and Business Overview
8.10.3 Chronic Migraine Treatment Introduction
8.10.4 Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2014-2019)
8.10.5 Alder BioPharmaceuticals Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Chronic Migraine Treatment Key Market Segments
Table Key Players Chronic Migraine Treatment Covered
Table Global Chronic Migraine Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Treatment Figures
Table Key Players of Drug Treatment
Figuer Substitution Treatment Figures
Table Key Players of Substitution Treatment
Table Global Chronic Migraine Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Chronic Migraine Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Chronic Migraine Treatment Report Years Considered
Figure Global Chronic Migraine Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chronic Migraine Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Chronic Migraine Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Chronic Migraine Treatment Market Share by Regions 2014-2019
Figure Global Chronic Migraine Treatment Market Share by Regions 2014-2019
Figure Global Chronic Migraine Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Chronic Migraine Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Chronic Migraine Treatment Market Share by by Players (2014-2019)
Figure Global Chronic Migraine Treatment Market Share by by Players in 2018
Table Global Chronic Migraine Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Migraine Treatment Product/Solution/Service
Table Date of Enter into Chronic Migraine Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Migraine Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Chronic Migraine Treatment Market Size Share by Type (2014-2019)
Figure Global Chronic Migraine Treatment Market Size Market Share by Type (2014-2019)
Table Global Chronic Migraine Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Chronic Migraine Treatment Market Size Share by Application (2014-2019)
Figure Global Chronic Migraine Treatment Market Size Market Share by Application (2014-2019)
Figure Global Chronic Migraine Treatment Revenue Market Share by Application in 2018
Figure North America Chronic Migraine Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Chronic Migraine Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Chronic Migraine Treatment Market Share (2018-2019)
Table North America Chronic Migraine Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Chronic Migraine Treatment Market Share by Type 2014-2019
Table North America Chronic Migraine Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Chronic Migraine Treatment Market Share by Application 2014-2019
Figure Europe Chronic Migraine Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Chronic Migraine Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Chronic Migraine Treatment Market Share (2018-2019)
Table Europe Chronic Migraine Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Chronic Migraine Treatment Market Share by Type 2014-2019
Table Europe Chronic Migraine Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Chronic Migraine Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Chronic Migraine Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Chronic Migraine Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Chronic Migraine Treatment Market Share (2018-2019)
Table Asia-Pacific Chronic Migraine Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Chronic Migraine Treatment Market Share by Type 2014-2019
Table Asia-Pacific Chronic Migraine Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Chronic Migraine Treatment Market Share by Application 2014-2019
Table Novartis Company Details
Table Novartis Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Allergan Company Details
Table Allergan Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Allergan Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Eli Lilly Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Merck Company Details
Table Merck Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Merck Recent Development
Table Johnson&Johnson Company Details
Table Johnson&Johnson Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Johnson&Johnson Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Johnson&Johnson Recent Development
Table Zosano Company Details
Table Zosano Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Zosano Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Zosano Recent Development
Table Alder BioPharmaceuticals Company Details
Table Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business 2014-2019 (Million US$)
Figure Alder BioPharmaceuticals Revenue Growth Rate in Chronic Migraine Treatment Business (2014-2019)
Table Alder BioPharmaceuticals Recent Development
Table Global Chronic Migraine Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Chronic Migraine Treatment Market Size Share by Regions (2019-2025)
Figure Global Chronic Migraine Treatment Market Size Share by Regions in 2025
Figure North America Chronic Migraine Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chronic Migraine Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Chronic Migraine Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Chronic Migraine Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Chronic Migraine Treatment Market Size by Product (2019-2025)
Figure Global Chronic Migraine Treatment Market Size by Product in 2025
Table Global Chronic Migraine Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Chronic Migraine Treatment Market Size by Application (2019-2025)
Figure Global Chronic Migraine Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis、Pfizer、AstraZeneca、Allergan、GlaxoSmithKline、Eli Lilly、Merck、Johnson&Johnson、Zosano、Alder BioPharmaceuticals

★調査レポート[慢性片頭痛治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18277)販売に関する免責事項を必ずご確認ください。
★調査レポート[慢性片頭痛治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 慢性ケア管理ソフトウェアの世界市場：規模・現状・予測2019-2025
    DATA909X18276 / QYResearch / 2019年11月25日 / ※当調査レポートでは、慢性ケア管理ソフトウェアの世界市場について調査・分析し、慢性ケア管理ソフトウェアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（オンクラウド、オンプレミス）、用途別（大企業、中小企業）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性ケア管理ソフトウェア市場動向 ・主要企業別マーケットシェア ・慢性ケア管理ソフトウェアの種類別市場規模2014-2019 （オンクラウド、オンプレミス） ・慢性ケア管理ソフトウェアの用途別市場規模2014-2019 （大企業、中小企業） ・慢性ケア管理ソフトウェアの北米市場：主要企業・種類別/用途別市場規模 ・慢性ケア管理ソフトウェアのヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Chronic Care Management Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Chronic Care Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Care Management Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study AdvancedMD Kareo Billing athenahealth EHR NextGen Healthcare Kareo Clinical EHR Practice Fusion...
  • B型肝炎治療の世界市場：規模・現状・予測2019-2025
    DATA909X18539 / QYResearch / 2019年11月25日 / ※当調査レポートでは、B型肝炎治療の世界市場について調査・分析し、B型肝炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（急性、慢性）、用途別（免疫調節薬、抗ウイルス薬）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のB型肝炎治療市場動向 ・主要企業別マーケットシェア ・B型肝炎治療の種類別市場規模2014-2019 （急性、慢性） ・B型肝炎治療の用途別市場規模2014-2019 （免疫調節薬、抗ウイルス薬） ・B型肝炎治療の北米市場：主要企業・種類別/用途別市場規模 ・B型肝炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. In 2018, the global Hepatitis B Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hepatitis B Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study...

    • ◆H&Iグローバルリサーチのお客様（例）◆